ID

11715

Descrizione

This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135

collegamento

https://clinicaltrials.gov/ct2/show/NCT00356135

Keywords

versioni (1)
  1. 28/07/15 28/07/15 -
Caricato su

28 luglio 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility SWAP Acute Coronary Syndrome NCT00356135

Inglese

Eligibility Criteria

1 moduli  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Descrizione

Inclusion Criteria

Present with a recent history of an ACS event
Descrizione

Present with a recent history of an ACS event

Tipo di dati

boolean

Alias
UMLS CUI-1
C0948089
who state that they are supposed to be taking daily aspirin
Descrizione

who state that they are supposed to be taking daily aspirin

Tipo di dati

boolean

Alias
UMLS CUI-1
C0004057
who state that they are supposed to be taking maintenance dose 75-mg clopidogrel.
Descrizione

who state that they are supposed to be taking maintenance dose 75-mg clopidogrel.

Tipo di dati

boolean

Alias
UMLS CUI-1
C0070166
Are of a legal age (and at least 18 years of age but less than 75 years of age)
Descrizione

Are of a legal age (and at least 18 years of age but less than 75 years of age)

Tipo di dati

boolean

Alias
UMLS CUI-1
C0001779
Are competent mental condition to provide written informed consent before entering the study.
Descrizione

Are competent mental condition to provide written informed consent before entering the study.

Tipo di dati

boolean

Alias
UMLS CUI-1
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Left main coronary artery stent
Descrizione

Left main coronary artery stent

Tipo di dati

boolean

Alias
UMLS CUI-1
N
left anterior descending (LAD) bifurcation stent
Descrizione

left anterior descending (LAD) bifurcation stent

Tipo di dati

boolean

Alias
UMLS CUI-1
C3836455
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Descrizione

Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).

Tipo di dati

boolean

Alias
UMLS CUI-1
C1532338
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Descrizione

Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).

Tipo di dati

boolean

Alias
UMLS CUI-1
C0010055
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Descrizione

Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.

Tipo di dati

boolean

Alias
UMLS CUI-1
C0354604
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Descrizione

Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.

Tipo di dati

boolean

Alias
UMLS CUI-1
C1096021
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Descrizione

Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.

Tipo di dati

boolean

Alias
UMLS CUI-1
C0003211
history of ischemic or hemorrhagic stroke
Descrizione

history of ischemic or hemorrhagic stroke

Tipo di dati

boolean

Alias
UMLS CUI-1
C0559159
Intracranial neoplasm
Descrizione

Intracranial neoplasm

Tipo di dati

boolean

Alias
UMLS CUI-1
C1527390
Arteriovenous malformation
Descrizione

Arteriovenous malformation

Tipo di dati

boolean

Alias
UMLS CUI-1
C0003857
Aneurysm
Descrizione

Aneurysm

Tipo di dati

boolean

Alias
UMLS CUI-1
C0002940
History of transient ischemic attack (TIA)
Descrizione

History of transient ischemic attack (TIA)

Tipo di dati

boolean

Alias
UMLS CUI-1
C0455536
Have a body weight less than 60 kilograms (kg)
Descrizione

Have a body weight less than 60 kilograms (kg)

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Eligibility Criteria

1 moduli
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
Acute coronary syndrome
Item
Present with a recent history of an ACS event
boolean
C0948089 (UMLS CUI-1)
Aspirin
Item
who state that they are supposed to be taking daily aspirin
boolean
C0004057 (UMLS CUI-1)
Clopidogrel
Item
who state that they are supposed to be taking maintenance dose 75-mg clopidogrel.
boolean
C0070166 (UMLS CUI-1)
Age
Item
Are of a legal age (and at least 18 years of age but less than 75 years of age)
boolean
C0001779 (UMLS CUI-1)
Informed consent
Item
Are competent mental condition to provide written informed consent before entering the study.
boolean
C0021430 (UMLS CUI-1)
Item Group
Exclusion Criteria
Left main coronary artery stent
Item
Left main coronary artery stent
boolean
N (UMLS CUI-1)
left anterior descending (LAD) bifurcation stent
Item
left anterior descending (LAD) bifurcation stent
boolean
C3836455 (UMLS CUI-1)
PCI
Item
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
boolean
C1532338 (UMLS CUI-1)
CABG
Item
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
boolean
C0010055 (UMLS CUI-1)
Oral anticoagulants
Item
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
boolean
C0354604 (UMLS CUI-1)
Antiplatelet therapy
Item
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
boolean
C1096021 (UMLS CUI-1)
NSAID
Item
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
boolean
C0003211 (UMLS CUI-1)
History of stroke
Item
history of ischemic or hemorrhagic stroke
boolean
C0559159 (UMLS CUI-1)
Intracranial neoplasm
Item
Intracranial neoplasm
boolean
C1527390 (UMLS CUI-1)
Arteriovenous malformation
Item
Arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
Aneurysm
Item
Aneurysm
boolean
C0002940 (UMLS CUI-1)
History of TIA
Item
History of transient ischemic attack (TIA)
boolean
C0455536 (UMLS CUI-1)
Weight
Item
Have a body weight less than 60 kilograms (kg)
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial